Molecular Mechanism of Action of 2-Ferrocenyl-1,1-diphenylbut-1-ene on HL-60 Leukemia Cells-Reference-Cited by-同舟云学术

Molecular Mechanism of Action of 2-Ferrocenyl-1,1-diphenylbut-1-ene on HL-60 Leukemia Cells

Published:2014-08-25 Issue:11 Volume:9 Page:2580-2586
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

de Oliveira Alane Cabral,da Silva Emanuella Gomes,Rocha Danilo Damasceno,Hillard Elizabeth A.,Pigeon Pascal,Jaouen Gérard,Rodrigues Felipe A. R.,de Abreu Fabiane C.,da Rocha Ferreira Fabrícia,Goulart Marilia O. F.,Costa-Lotufo Letícia V.

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference63 articles.

1. Organometallic Anticancer Compounds

2. A New Age for Iron: Antitumoral Ferrocenes

3. Ferrocene–Biotin Conjugates Targeting Cancer Cells: Synthesis, Interaction with Avidin, Cytotoxic Properties and the Crystal Structure of the Complex of Avidin with a Biotin–Linker–Ferrocene Conjugate

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping the Landscape of Global Anticancer Organometallics Research: A Systematic Review;Medicinal Chemistry;2024-08-29

2. Riding the metal wave: A review of the latest developments in metal-based anticancer agents;Coordination Chemistry Reviews;2024-02

3. In Vitro Anticancer Activity of Two Ferrocene-Containing Camphor Sulfonamides as Promising Agents against Lung Cancer Cells;Biomedicines;2022-06-08

4. Enhancing the Activity of Drugs by Conjugation to Organometallic Fragments;Chemistry – A European Journal;2020-05-26

5. Recent advances in iron-complexes as drug candidates for cancer therapy: reactivity, mechanism of action and metabolites;Dalton Transactions;2020